Vimta Labs P/B Ratio
VIMTALABS • Price-to-Book ratio analysis and book value breakdown
Current P/B Ratio
8.04
High Valuation
Very High - Significant premium, high growth expectations or speculative
Current Valuation Metrics
P/B Ratio
8.04
Current Price
₹602.15
Book Value/Share
₹800.00
Exchange
NSE
Book Value Breakdown (2024)
Balance Sheet Components
Total Equity
₹320 Cr
Share Capital
₹4 Cr
Reserves & Surplus
₹315 Cr
Outstanding Shares
4,000,000
Book Value per Share
₹800.00
Valuation Signal
Signal
Overvalued
Historical Avg
0.38
Historical Range
0.2 - 0.62
Percentile
100.0%
Sector Context
Sector Average
-0.1
Sector Median
0.66
Sector Rank
#11 of 50
Sector Percentile
22.0%
Key P/B Ratio Insights for Vimta Labs
- Stock appears overvalued with PB of 8.04, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 2015.8% above historical average
- Trading at premium to sector average PB of -0.1
View the current stock price of Vimta Labs for more insights.
P/B Ratio Historical Trend for Vimta Labs
Historical P/B ratio trend based on balance sheet data. P/B below 1.0 may indicate undervaluation, while higher ratios suggest growth expectations or asset-light business models.
Related Pages for Vimta Labs
Additional stock information and data for VIMTALABS
Historical P/B Ratio Data
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2024 | 0.62 | ₹800.0 | ₹497.10 | ₹320 | Low |
| 2023 | 0.29 | ₹705.0 | ₹201.80 | ₹282 | Low |
| 2022 | 0.37 | ₹585.0 | ₹218.20 | ₹234 | Low |
| 2021 | 0.42 | ₹485.0 | ₹204.50 | ₹194 | Low |
| 2020 | 0.2 | ₹432.5 | ₹87.00 | ₹173 | Low |
Sector P/B Ratio Comparison
Comparing Vimta Labs with other companies in Healthcare sector
Sector Average
-0.1
Sector Median
0.66
Lowest P/B
-12.97
Highest P/B
1.2
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sun Pharma Advanced Rese… | SPARC | -12.97 | ₹4,391 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.47 | ₹95 | Low |
| Parmax Pharma | PARMAX | -2.15 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.96 | ₹154 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |
| Murae Organisor | MURAE | 0.26 | ₹55 | Low |